(1 - 22 von 26
)
92. Generalversammlung der Vifor Pharma Gruppe www.pr-inside.com › generalversammlung-der-vifor-pharma-r
www.pr-inside.com
· Generalversammlung der Vifor Pharma Gruppe. Media Relations Nathalie Ponnier Global Head Corporate Communications +
Vifor Pharma acquires Priority Review Voucher
www.finanznachrichten.de
Media Relations Nathalie Ponnier Global Head Corporate Communications + Investor Relations Julien Vignot Head of …
ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal...
ir.chemocentryx.com
· , Vifor Pharma Contacts: Media Relations Nathalie Ponnier Global Head Corporate Communications +
Vifor Pharma Appoints Gregory Oakes as President North America and...
www.finanznachrichten.de
Regulatory News: Vifor Pharma today announced the appointment of Gregory Oakes as EVP, President North America and member of the Vifor Pharma Executive...
Evotec And Vifor Pharma Form Joint Venture For Early Development In...
apnews.com
Media Relations Nathalie Ponnier Global Head Corporate Communications + , Investor Relations Julien Vignot Head of ...
Vifor Pharma Appoints Lee Heeson as President International and...
www.finanznachrichten.de
Regulatory News: Vifor Pharma today announced the appointment of Lee Heeson as President International and member of the Executive Committee as of February...
92. Generalversammlung der Vifor Pharma Gruppe | news | onvista
www.onvista.de
Alle Beschlussanträge des Verwaltungsrats von den Aktionären genehmigt Jacques Theurillat zum neuen Verwaltungsratspräsidenten gewählt Etienne Jornod zum...
92nd Vifor Pharma Group Annual General Meeting | Pembroke Daily...
www.pembrokeobserver.com
Shareholders agreed to the Board of Directors’ recommendations for all proposed resolutions Election of Jacques Theurillat as new Chairman of the Board of...
newarticle – Boersengefluester
www.boersengefluester.de
Media Relations Nathalie Ponnier Global Head Corporate Communications + , Investor Relations Julien Vignot
| Press Release | Vifor Pharma Appoints Gregory Oakes as...
stockhouse.com
Vifor Pharma Appoints Gregory Oakes as President North America and Member of the Executive Committee
VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial...
financialpost.com
Nathalie Ponnier Global Head Corporate Communications + Investor Relations Julien Vignot
Update on 92nd Vifor Pharma Ltd. Annual General Meeting
www.globalbankingandfinance.com
Regulatory News:
Vifor Pharma Gruppe erzielt starkes Wachstum und übertrifft die...
www.onvista.de
· Media Relations Nathalie Ponnier. Global Head of Corporate Communications. + Investor Relations ...
VFMCRP and ChemoCentryx announce European Medicines ...www.businesswirechina.com › news
www.businesswirechina.com
Nathalie Ponnier Global Head Corporate Communications + Investor Relations Julien Vignot
Vifor Pharma Group Reports Continued Growth in H ANSA.itwwww.ansalatina.com › ... › Business Wire - Notizie
wwww.ansalatina.com
· View source version on businesswire.com: https://www.businesswire.com/news/ home en/. Media Relations Nathalie Ponnier
Vifor Pharma Group Announces Successful Sale of OM Pharma
www.globalbankingandfinance.com
Regulatory News:
Vifor Pharma announces the initiation of S&P credit rating coverage...
www.globalbankingandfinance.com
Regulatory News:
Stockwatch
www.stockwatch.com
No Hype - just the Facts. Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, Montreal, Nasdaq, NYSE, Amex and OTC Markets.
Vifor Pharma and Fresenius Kabi create joint QLifeProwww.qlifepro.com › Home
www.qlifepro.com
Nathalie Ponnier Global Head Corporate Communications + Investor Relations Julien Vignot
Vifor Pharma and Angion Sign License Agreement for ANG in...
www.einnews.com
Vifor Pharma acquires a worldwide license, excluding Greater China, to late-stage product ANG ANG is a first-in-class small-molecule hepatocyte growth
Vifor Pharma announces outcome of AFFIRM-AHF topline data | Brantford...
www.brantfordexpositor.ca
Nathalie Ponnier Global Head Corporate Communications + Investor Relations Julien Vignot
EVOTEC UND VIFOR PHARMA GRÜNDEN JOINT VENTURE FÜR FRÜHPHASIGE...
www.eqs-news.com
EVOTEC UND VIFOR PHARMA GRÜNDEN JOINT VENTURE FÜR FRÜHPHASIGE ENTWICKLUNG IM BEREICH NEPHROLOGIE | Evotec SE | News | Nachricht | Mitteilung
sortiert nach Relevanz / Datum